This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen (PSA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen (PSA) Testing. This report contains market size and forecasts of Prostate Specific Antigen (PSA) Testing in global, including the following market information:
Global Prostate Specific Antigen (PSA) Testing Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Specific Antigen (PSA) Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radioimmunoassay Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, Roche Holding AG, Beckman Coulter, Mediwatch(LABORIE), Boditech and Bristol Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Prostate Specific Antigen (PSA) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Specific Antigen (PSA) Testing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Type, 2022 (%)
Radioimmunoassay
Enzyme Immunoassay
Global Prostate Specific Antigen (PSA) Testing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
Global Prostate Specific Antigen (PSA) Testing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Specific Antigen (PSA) Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Specific Antigen (PSA) Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Specific Antigen (PSA) Testing, market overview.
Chapter 2: Global Prostate Specific Antigen (PSA) Testing market size in revenue.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Specific Antigen (PSA) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Specific Antigen (PSA) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Specific Antigen (PSA) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Specific Antigen (PSA) Testing Overall Market Size
2.1 Global Prostate Specific Antigen (PSA) Testing Market Size: 2022 VS 2032
2.2 Global Prostate Specific Antigen (PSA) Testing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Specific Antigen (PSA) Testing Players in Global Market
3.2 Top Global Prostate Specific Antigen (PSA) Testing Companies Ranked by Revenue
3.3 Global Prostate Specific Antigen (PSA) Testing Revenue by Companies
3.4 Top 3 and Top 5 Prostate Specific Antigen (PSA) Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Specific Antigen (PSA) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Players in Global Market
3.6.1 List of Global Tier 1 Prostate Specific Antigen (PSA) Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Specific Antigen (PSA) Testing Market Size Markets, 2022 & 2032
4.1.2 Radioimmunoassay
4.1.3 Enzyme Immunoassay
4.2 By Type - Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
4.2.1 By Type - Global Prostate Specific Antigen (PSA) Testing Revenue, 2018-2023
4.2.2 By Type - Global Prostate Specific Antigen (PSA) Testing Revenue, 2024-2032
4.2.3 By Type - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Specific Antigen (PSA) Testing Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Research Institute
5.1.6 Others
5.2 By Application - Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
5.2.1 By Application - Global Prostate Specific Antigen (PSA) Testing Revenue, 2018-2023
5.2.2 By Application - Global Prostate Specific Antigen (PSA) Testing Revenue, 2024-2032
5.2.3 By Application - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Prostate Specific Antigen (PSA) Testing Market Size, 2022 & 2032
6.2 By Region - Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
6.2.1 By Region - Global Prostate Specific Antigen (PSA) Testing Revenue, 2018-2023
6.2.2 By Region - Global Prostate Specific Antigen (PSA) Testing Revenue, 2024-2032
6.2.3 By Region - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032
6.3.2 US Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.3.3 Canada Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.3.4 Mexico Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032
6.4.2 Germany Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.3 France Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.4 U.K. Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.5 Italy Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.6 Russia Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.7 Nordic Countries Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.4.8 Benelux Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032
6.5.2 China Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.5.3 Japan Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.5.4 South Korea Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.5.5 Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.5.6 India Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032
6.6.2 Brazil Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.6.3 Argentina Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032
6.7.2 Turkey Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.7.3 Israel Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.7.4 Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
6.7.5 UAE Prostate Specific Antigen (PSA) Testing Market Size, 2018-2032
7 Prostate Specific Antigen (PSA) Testing Companies Profiles
7.1 Cleveland Diagnostics
7.1.1 Cleveland Diagnostics Company Summary
7.1.2 Cleveland Diagnostics Business Overview
7.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.1.4 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.1.5 Cleveland Diagnostics Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.2.4 Abbott Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Company Summary
7.3.2 Siemens Healthineers Business Overview
7.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.3.4 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.3.5 Siemens Healthineers Key News & Latest Developments
7.4 DiaSorin
7.4.1 DiaSorin Company Summary
7.4.2 DiaSorin Business Overview
7.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.4.4 DiaSorin Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.4.5 DiaSorin Key News & Latest Developments
7.5 Roche Holding AG
7.5.1 Roche Holding AG Company Summary
7.5.2 Roche Holding AG Business Overview
7.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.5.4 Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.5.5 Roche Holding AG Key News & Latest Developments
7.6 Beckman Coulter
7.6.1 Beckman Coulter Company Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.6.4 Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.6.5 Beckman Coulter Key News & Latest Developments
7.7 Mediwatch(LABORIE)
7.7.1 Mediwatch(LABORIE) Company Summary
7.7.2 Mediwatch(LABORIE) Business Overview
7.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.7.4 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.7.5 Mediwatch(LABORIE) Key News & Latest Developments
7.8 Boditech
7.8.1 Boditech Company Summary
7.8.2 Boditech Business Overview
7.8.3 Boditech Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.8.4 Boditech Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.8.5 Boditech Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.9.4 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 GE Healthcare
7.10.1 GE Healthcare Company Summary
7.10.2 GE Healthcare Business Overview
7.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.10.4 GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.10.5 GE Healthcare Key News & Latest Developments
7.11 Endocare
7.11.1 Endocare Company Summary
7.11.2 Endocare Business Overview
7.11.3 Endocare Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.11.4 Endocare Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.11.5 Endocare Key News & Latest Developments
7.12 GlaxoSmith Kline
7.12.1 GlaxoSmith Kline Company Summary
7.12.2 GlaxoSmith Kline Business Overview
7.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.12.4 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.12.5 GlaxoSmith Kline Key News & Latest Developments
7.13 Anixa Biosciences
7.13.1 Anixa Biosciences Company Summary
7.13.2 Anixa Biosciences Business Overview
7.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.13.4 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.13.5 Anixa Biosciences Key News & Latest Developments
7.14 Ortho Clinical
7.14.1 Ortho Clinical Company Summary
7.14.2 Ortho Clinical Business Overview
7.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.14.4 Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.14.5 Ortho Clinical Key News & Latest Developments
7.15 Fujirebio
7.15.1 Fujirebio Company Summary
7.15.2 Fujirebio Business Overview
7.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.15.4 Fujirebio Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.15.5 Fujirebio Key News & Latest Developments
7.16 Merck
7.16.1 Merck Company Summary
7.16.2 Merck Business Overview
7.16.3 Merck Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.16.4 Merck Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2018-2023)
7.16.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Specific Antigen (PSA) Testing Market Opportunities & Trends in Global Market
Table 2. Prostate Specific Antigen (PSA) Testing Market Drivers in Global Market
Table 3. Prostate Specific Antigen (PSA) Testing Market Restraints in Global Market
Table 4. Key Players of Prostate Specific Antigen (PSA) Testing in Global Market
Table 5. Top Prostate Specific Antigen (PSA) Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Specific Antigen (PSA) Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Specific Antigen (PSA) Testing Product Type
Table 9. List of Global Tier 1 Prostate Specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2024-2032
Table 30. Cleveland Diagnostics Company Summary
Table 31. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Offerings
Table 32. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Cleveland Diagnostics Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Prostate Specific Antigen (PSA) Testing Product Offerings
Table 36. Abbott Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Siemens Healthineers Company Summary
Table 39. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Offerings
Table 40. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Siemens Healthineers Key News & Latest Developments
Table 42. DiaSorin Company Summary
Table 43. DiaSorin Prostate Specific Antigen (PSA) Testing Product Offerings
Table 44. DiaSorin Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 45. DiaSorin Key News & Latest Developments
Table 46. Roche Holding AG Company Summary
Table 47. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Offerings
Table 48. Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Holding AG Key News & Latest Developments
Table 50. Beckman Coulter Company Summary
Table 51. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Offerings
Table 52. Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Beckman Coulter Key News & Latest Developments
Table 54. Mediwatch(LABORIE) Company Summary
Table 55. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Offerings
Table 56. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Mediwatch(LABORIE) Key News & Latest Developments
Table 58. Boditech Company Summary
Table 59. Boditech Prostate Specific Antigen (PSA) Testing Product Offerings
Table 60. Boditech Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Boditech Key News & Latest Developments
Table 62. Bristol Myers Squibb Company Summary
Table 63. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Offerings
Table 64. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Key News & Latest Developments
Table 66. GE Healthcare Company Summary
Table 67. GE Healthcare Prostate Specific Antigen (PSA) Testing Product Offerings
Table 68. GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 69. GE Healthcare Key News & Latest Developments
Table 70. Endocare Company Summary
Table 71. Endocare Prostate Specific Antigen (PSA) Testing Product Offerings
Table 72. Endocare Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Endocare Key News & Latest Developments
Table 74. GlaxoSmith Kline Company Summary
Table 75. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Offerings
Table 76. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 77. GlaxoSmith Kline Key News & Latest Developments
Table 78. Anixa Biosciences Company Summary
Table 79. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Offerings
Table 80. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 81. Anixa Biosciences Key News & Latest Developments
Table 82. Ortho Clinical Company Summary
Table 83. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Offerings
Table 84. Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 85. Ortho Clinical Key News & Latest Developments
Table 86. Fujirebio Company Summary
Table 87. Fujirebio Prostate Specific Antigen (PSA) Testing Product Offerings
Table 88. Fujirebio Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 89. Fujirebio Key News & Latest Developments
Table 90. Merck Company Summary
Table 91. Merck Prostate Specific Antigen (PSA) Testing Product Offerings
Table 92. Merck Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn) & (2018-2023)
Table 93. Merck Key News & Latest Developments
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Testing Segment by Type in 2022
Figure 2. Prostate Specific Antigen (PSA) Testing Segment by Application in 2022
Figure 3. Global Prostate Specific Antigen (PSA) Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Specific Antigen (PSA) Testing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Prostate Specific Antigen (PSA) Testing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2022
Figure 8. By Type - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 16. US Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 20. Germany Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 21. France Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 28. China Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 32. India Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 34. Brazil Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2018-2032
Figure 37. Turkey Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2018-2032
Figure 41. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DiaSorin Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boditech Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Endocare Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Fujirebio Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Merck Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
